Luzelena Caro
- Epidemiology top 10%
- Hepatology top 2%
- Infectious Diseases top 5%
- Pharmacology top 5%
- Oncology
- Co-authors
- Richard B. DickinsonDaniel L. PurichElizabeth G. RheeKajal LarsonBrian YuS. Aubrey StochIain P. FraserStephanie O. Klopfer
- Topics
- Hepatitis C virus research (32 papers)HIV/AIDS drug development and treatment (25 papers)Antibiotics Pharmacokinetics and Efficacy (10 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe EMBO JournalGastroenterology
- Partner nations
- United StatesJapanGermany
In The Last Decade
Luzelena Caro
56 papers receiving 986 citations
Peers
Comparison fields: 5 of 84
- Epidemiology 456
- Hepatology 325
- Infectious Diseases 249
- Pharmacology 194
- Oncology 157
Countries citing papers authored by Luzelena Caro
This map shows the geographic impact of Luzelena Caro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luzelena Caro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luzelena Caro more than expected).
Fields of papers citing papers by Luzelena Caro
This network shows the impact of papers produced by Luzelena Caro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luzelena Caro. The network helps show where Luzelena Caro may publish in the future.
Co-authorship network of co-authors of Luzelena Caro
This figure shows the co-authorship network connecting the top 25 collaborators of Luzelena Caro. A scholar is included among the top collaborators of Luzelena Caro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luzelena Caro. Luzelena Caro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 16 | |
| 5 | 27 | |
| 6 | 5 | |
| 7 | A Single- and Multiple-Dose Study to Evaluate the Pharmacokinetics of Fixed-Dose Grazoprevir/Elbasvir in Healthy Chinese Participants | 1 |
| 8 | 10 | |
| 9 | 12 | |
| 10 | 7 | |
| 11 | 10 | |
| 12 | 14 | |
| 13 | 4 | |
| 14 | 51 | |
| 15 | 33 | |
| 16 | 28 | |
| 17 | 144 | |
| 18 | Safety and pharmacokinetics of single and multiple oral doses of MK-8742, an HCV NS5A inhibitor, in healthy subjects | 3 |
| 19 | 26 | |
| 20 | 27 |
About Luzelena Caro
Luzelena Caro is a scholar working on Hepatology, Infectious Diseases and Molecular Medicine, having authored 59 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (32 papers), HIV/AIDS drug development and treatment (25 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). The work is most often cited by research in Hepatology (325 citations), Molecular Medicine (151 citations) and Applied Microbiology and Biotechnology (59 citations). Luzelena Caro has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Richard B. Dickinson, Daniel L. Purich, Elizabeth G. Rhee, Kajal Larson, Brian Yu, S. Aubrey Stoch, Iain P. Fraser, Stephanie O. Klopfer, Matthew L. Rizk and Michael Robertson. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.